IPP Bureau
Divis Labs PAT at Rs 606.46 cr. in Q2FY22
By IPP Bureau - November 08, 2021
Divi's Laboratories Limited has reported consolidated financial results for the period ended September 30, 2021.
Lupin launches fenofibrate in the US
By IPP Bureau - November 08, 2021
The drug helps in managing cholesterol
Govt places orders for one crore doses of ZyCoV-D
By IPP Bureau - November 08, 2021
It is the world’s first DNA-based Covid vaccine
Meiji Seika Pharma to build new facility in Bangalore to expand CMO business
By IPP Bureau - November 08, 2021
The new manufacturing facility will be built at a subsidiary of Adcock Ingram and will commence operation in March 23
UK authorises first Covid-19 pill
By IPP Bureau - November 05, 2021
Applications remain under review by others including U.S. Food and Drug Administration and the European Medicines Agency
Novavax files emergency use listing with WHO for Covid-19 vaccine
By IPP Bureau - November 05, 2021
All modules required for regulatory review of Novavax vaccine, including CMC data, are now complete for WHO
CorporateServe launches PharmaSoft 2.0
By IPP Bureau - November 05, 2021
The solution helps the pharma enterprises drive efficiencies, save costs, and increase productivity
St. George’s University School of Medicine to host a webinar for aspiring doctors
By IPP Bureau - November 05, 2021
The students can interact with resident doctors and graduates of SGU
Aster Medcity Kochi launches Cryo-ablation procedure to tackle heart disease
By IPP Bureau - November 05, 2021
The process is completed with the help of a balloon at a low temperature so that other cells are undamaged and the patient can return home the next day
CIMS doctors perform heart transplant on 15-year-old in Ahmedabad
By IPP Bureau - November 05, 2021
The transplant procedure was completed in under two hours
Prime Therapeutics to list Semglee and Insulin Glargine
By IPP Bureau - November 05, 2021
Biocon Biologics and Viatris co-developed the products
Shilpa Biologics permitted to conduct Phase 1 study on NavAlbumin
By IPP Bureau - November 05, 2021
The product is synthetically developed as compared to the current process of drawing the same from blood plasma and is backed by a granted global patent
Venus Remedies H1 net profit rises 315%
By IPP Bureau - November 03, 2021
Venus Remedies has reported consolidated financial results for the period ended September 30, 2021
Moderna and Metagenomi partner to develop next-gen in vivo gene editing therapeutics
By IPP Bureau - November 03, 2021
The collaboration will combine Metagenomi’s next-generation CRISPR-based and other novel gene editing systems with Moderna’s mRNA and LNP technologies
Shalby commences pre-registration for kids' covid vaccine
By IPP Bureau - November 03, 2021
The preregistrations are aimed at registering both healthy children and those with comorbidities whereas preference will be given for children with comorbidities
